0001567619-18-007099.txt : 20181129 0001567619-18-007099.hdr.sgml : 20181129 20181129125228 ACCESSION NUMBER: 0001567619-18-007099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181127 FILED AS OF DATE: 20181129 DATE AS OF CHANGE: 20181129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ESSEX WOODLANDS HEALTH VENTURES FUND VII LP CENTRAL INDEX KEY: 0001367998 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36375 FILM NUMBER: 181207713 BUSINESS ADDRESS: STREET 1: 21 WATERWAY AVENUE STREET 2: SUITE 225 CITY: THE WOODLANDS STATE: TX ZIP: 77380 BUSINESS PHONE: 2813648338 MAIL ADDRESS: STREET 1: 21 WATERWAY AVENUE STREET 2: SUITE 225 CITY: THE WOODLANDS STATE: TX ZIP: 77380 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Corium International, Inc. CENTRAL INDEX KEY: 0001594337 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383230774 STATE OF INCORPORATION: DE FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 235 CONSTITUTION DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 BUSINESS PHONE: 650-298-8012 MAIL ADDRESS: STREET 1: 235 CONSTITUTION DRIVE CITY: MENLO PARK STATE: CA ZIP: 94025 4 1 doc1.xml FORM 4 X0306 4 2018-11-27 1 0001594337 Corium International, Inc. CORI 0001367998 ESSEX WOODLANDS HEALTH VENTURES FUND VII LP C/O ESSEX WOODLANDS HEALTH VENTURES 335 BRYANT STREET, THIRD FLOOR PALO ALTO CA 94301 0 0 1 0 Common Stock 2018-11-27 4 U 0 9353304 12.50 D 0 D Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the "Merger Agreement"), between Corium International, Inc. (the "Company"), Gurnet Holding Company ("Parent") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a "Share") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a "CVR"). /s/Martin Sutter 2018-11-28